GL1X · GenesisL1 explorer

Research workbench

Crystal structure of an engineered botulinum neurotoxin type B-derivative, lc-B-gs-hn-B

Analyse Crystal structure of an engineered botulinum neurotoxin type B-derivative… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3ZUQ
Type
protein
Length
850 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Botulinum neurotoxin type B
EC
3.4.24.69
UniProt
P10844
Ligands
ZN
Pockets
9 · best druggability 0.78

Structure

x-ray diffraction · 1 distinct chain · 42% helix, 14% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABotulinum neurotoxin type B (EC 3.4.24.69)protein85042% helix, 14% strandP10844

Ligands and binding sites

  • ZN · Zinc ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

9 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17950.780.8259ZN
25150.730.8276empty
35270.660.7755empty
41430.500.7929empty
5630.460.8318empty

Compared structures

  • 3ZUQ · Crystal structure of an engineered botulinum neurotoxin type B - derivative, LC-B-GS-Hn-B · the same entry in another collection · chain A against A, TM-score 1.00
  • P10844 · AlphaFold monomer V2.0 prediction for botulinum neurotoxin type B (P10844) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.